Adaptation to Chronic Hypoxia in Triple-negative Breast Cancer
Lead Research Organisation:
University of Oxford
Department Name: Oncology
Abstract
Low levels of oxygen (i.e. hypoxia) are often observed in solid tumours. Hypoxia is able to drive several of the cancer hallmarks and promotes resistance to both radio and chemotherapy, resulting in its association with poor prognosis. Triple-negative breast cancer has the worst prognosis of all breast cancer subtypes with a 5 year survival rate of only 76.7%, and only 10.8% if the cancer has already metastasised. In line with this, triple-negative tumours often have higher levels of hypoxia than their hormone receptor expressing counterparts. The length and severity of hypoxia is heterogeneous both within and between tumours, meaning cells within the same tumour may experience both acute and chronic hypoxia. Acute hypoxia (<=24 hours) is relatively well studied, whereas research into chronic hypoxia (>= 7 days) is lacking. This project therefore aims to characterise the transcriptional response to chronic hypoxia using RNA sequencing. It also aims to identify proteins or microRNAs which are necessary for adaptation to chronic hypoxia using genome-wide CRISPR screening. This method enables specific vulnerabilities in hypoxic cells to be identified, meaning drugs can be designed to target these "Achilles heels".
Organisations
People |
ORCID iD |
Francesca Buffa (Primary Supervisor) | |
Fiona Hartley (Student) |
Studentship Projects
Project Reference | Relationship | Related To | Start | End | Student Name |
---|---|---|---|---|---|
MR/N013468/1 | 01/10/2016 | 30/09/2025 | |||
2335478 | Studentship | MR/N013468/1 | 01/10/2019 | 30/09/2023 | Fiona Hartley |